BlackRock Japan’s Emergent Biosolutions EBS Stock Holding History

BlackRock Japan’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Buy	130 +68	+110%	+$2.04K	﹤0.01%	1265
2016 Q3	$2K	Sell	62 -893	-94%	-$25.9K	﹤0.01%	1291
2016 Q2	$27K	Buy	955 +209	+28%	+$8.19K	﹤0.01%	1104
2016 Q1	$27K	Buy	746 +39	+6%	+$1.38K	﹤0.01%	1141
2015 Q4	$28K	Sell	707 -84	-11%	-$2.93K	﹤0.01%	1115
2015 Q3	$23K	Hold	791	–	–	﹤0.01%	1076
2015 Q2	$26K	Sell	791 -626	-44%	-$19.4K	﹤0.01%	1158
2015 Q1	$41K	Sell	1,417 -356	-20%	-$10.2K	﹤0.01%	1094
2014 Q4	$48K	Sell	1,773 -985	-36%	-$23.5K	﹤0.01%	1104
2014 Q3	$59K	Sell	2,758 -482	-15%	-$11K	﹤0.01%	1026
2014 Q2	$73K	Sell	3,240 -740	-19%	-$17.2K	﹤0.01%	986
2014 Q1	$101K	Sell	3,980 -7,804	-66%	-$197K	﹤0.01%	1061
2013 Q4	$271K	Sell	11,784 -3,518	-23%	-$73.3K	﹤0.01%	857
2013 Q3	$292K	Buy	+15,302	New	+$273K	﹤0.01%	830

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's EBS Position: Q4 2016 in Review

BlackRock Japan increased its Emergent Biosolutions (EBS) stake by 110% in Q4 2016, buying an estimated $2.04K and bringing the position to 130 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

BlackRock Japan first reported a position in EBS in Q3 2013 and has held it in 14 quarters since. The position peaked at $292K in Q3 2013. 209 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

BlackRock Japan held 130 shares of Emergent Biosolutions worth $4K as of Q4 2016.
BlackRock Japan bought 68 Emergent Biosolutions shares in Q4 2016, an estimated $2.04K.
Emergent Biosolutions made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1265 holding.
BlackRock Japan first reported a position in Emergent Biosolutions in Q3 2013 and has held it in 14 quarters since.
BlackRock Japan's Emergent Biosolutions position peaked at $292K in Q3 2013.
209 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.